FRIEDMAN PAUL A
Insider CIK 1236927 · SNTA Chief Executive Officer, Director · AUXL Director · CERU Director · VSTM Director · DRTX Director · PRLD Director · INCY Chief Executive Officer, Director · ALXN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | A Award deriv | 2026-06-09 | 2026-06-10 | 38,000 | — | $0 | 38,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2026-01-09 | 2026-01-13 | 24,520 | — | $0 | 280 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2026-01-09 | 2026-01-13 | 280 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 846 | $519.88 | $439.8K | 200,344 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,363 | $518.68 | $707.0K | 201,190 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 766 | $516.84 | $395.9K | 205,003 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,996 | $515.81 | $1.03M | 205,769 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,345 | $514.68 | $692.2K | 207,765 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,094 | $513.11 | $561.3K | 209,110 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,480 | $511.98 | $757.7K | 210,204 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2026-01-09 | 2026-01-13 | 24,520 | $15.80 | $387.4K | 211,684 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 40 | $545.79 | $21.8K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 600 | $540.36 | $324.2K | 187,204 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 480 | $539.23 | $258.8K | 187,804 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 80 | $537.85 | $43.0K | 188,284 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 487 | $536.88 | $261.5K | 188,364 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 473 | $536.02 | $253.5K | 188,851 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 148 | $535.29 | $79.2K | 189,324 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 332 | $534.16 | $177.3K | 189,472 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 80 | $532.50 | $42.6K | 189,804 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 280 | $530.69 | $148.6K | 189,884 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 166 | $529.76 | $87.9K | 190,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 691 | $529.17 | $365.7K | 190,330 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 575 | $528.18 | $303.7K | 191,021 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,560 | $526.97 | $822.1K | 191,596 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,066 | $526.00 | $560.7K | 193,156 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 2,432 | $525.05 | $1.28M | 194,222 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 1,199 | $524.10 | $628.4K | 196,654 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 970 | $523.00 | $507.3K | 197,853 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 840 | $521.98 | $438.5K | 198,823 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 681 | $521.03 | $354.8K | 199,663 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 2,450 | $517.86 | $1.27M | 202,553 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2026-01-09 | 2026-01-13 | 280 | $551.24 | $154.3K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2026-01-09 | 2026-01-13 | 280 | $15.80 | $4.4K | 187,444 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-12-10 | 2025-12-12 | 24,800 | — | $0 | 24,800 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 7,193 | $551.67 | $3.97M | 198,887 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 4,316 | $550.93 | $2.38M | 206,080 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 409 | $549.99 | $224.9K | 210,396 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 535 | $548.51 | $293.5K | 210,805 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 624 | $547.75 | $341.8K | 211,340 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 5,533 | $552.74 | $3.06M | 193,354 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 5,001 | $553.83 | $2.77M | 188,353 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 1,029 | $555.00 | $571.1K | 187,324 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-12-10 | 2025-12-12 | 160 | $555.39 | $88.9K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-12-10 | 2025-12-12 | 24,800 | $15.80 | $391.8K | 211,964 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-08-13 | 2025-08-13 | 129,172 | — | $0 | 0 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 4,155 | $374.38 | $1.56M | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 24,166 | $373.35 | $9.02M | 191,319 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 28,976 | $372.39 | $10.79M | 215,485 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 22,710 | $371.53 | $8.44M | 244,461 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 7,877 | $370.44 | $2.92M | 267,171 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 7,992 | $369.44 | $2.95M | 275,048 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 6,788 | $368.34 | $2.50M | 283,040 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 7,119 | $367.31 | $2.61M | 289,828 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 3,152 | $366.22 | $1.15M | 296,947 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 1,716 | $365.19 | $626.7K | 300,099 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 3,529 | $364.02 | $1.28M | 301,815 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 2,591 | $363.08 | $940.7K | 305,344 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 1,439 | $362.29 | $521.3K | 307,935 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 1,754 | $361.13 | $633.4K | 309,374 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 3,153 | $360.27 | $1.14M | 311,128 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 455 | $359.31 | $163.5K | 314,281 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-13 | 2025-08-13 | 1,600 | $358.23 | $573.2K | 314,736 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-08-13 | 2025-08-13 | 129,172 | $9.45 | $1.22M | 316,336 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-08-12 | 2025-08-13 | 43,605 | — | $0 | 129,172 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 1,382 | $352.61 | $487.3K | 222,882 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 5,032 | $358.83 | $1.81M | 187,764 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 8,434 | $357.93 | $3.02M | 192,796 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 5,094 | $356.94 | $1.82M | 201,230 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 5,244 | $355.97 | $1.87M | 206,324 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 6,546 | $355.00 | $2.32M | 211,568 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 4,768 | $354.06 | $1.69M | 218,114 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 600 | $359.81 | $215.9K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 3,202 | $351.59 | $1.13M | 224,264 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-12 | 2025-08-13 | 3,303 | $350.93 | $1.16M | 227,466 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-08-12 | 2025-08-13 | 43,605 | $9.45 | $412.1K | 230,769 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-08-11 | 2025-08-13 | 3,203 | — | $0 | 172,777 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-11 | 2025-08-13 | 300 | $351.04 | $105.3K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-08-11 | 2025-08-13 | 2,903 | $350.19 | $1.02M | 187,464 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-08-11 | 2025-08-13 | 3,203 | $9.45 | $30.3K | 190,367 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-07-18 | 2025-07-22 | 1,400 | — | $0 | 175,980 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-07-18 | 2025-07-22 | 1,400 | $9.45 | $13.2K | 188,564 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-18 | 2025-07-22 | 1,400 | $350.03 | $490.0K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-07-17 | 2025-07-18 | 2,700 | — | $0 | 177,380 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-17 | 2025-07-18 | 700 | $351.57 | $246.1K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-17 | 2025-07-18 | 2,000 | $350.10 | $700.2K | 187,864 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-07-17 | 2025-07-18 | 2,700 | $9.45 | $25.5K | 189,864 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2025-07-16 | 2025-07-18 | 26,176 | — | $0 | 180,080 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 1,200 | $356.62 | $427.9K | 187,164 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 5,784 | $355.61 | $2.06M | 188,364 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 6,851 | $354.65 | $2.43M | 194,148 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 2,319 | $353.82 | $820.5K | 200,999 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 2,110 | $352.67 | $744.1K | 203,318 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 2,371 | $351.38 | $833.1K | 205,428 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2025-07-16 | 2025-07-18 | 5,541 | $350.17 | $1.94M | 207,799 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2025-07-16 | 2025-07-18 | 26,176 | $9.45 | $247.4K | 213,340 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2025-06-20 | 2025-06-24 | 1,290 | — | $0 | 1,290 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2025-06-20 | 2025-06-24 | 715 | — | $0 | 187,164 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2025-06-12 | 2025-06-13 | 38,000 | — | $0 | 38,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2024-06-25 | 2024-06-27 | 1,105 | — | $0 | 1,105 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2024-06-25 | 2024-06-27 | 714 | — | $0 | 186,449 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2024-06-14 | 2024-06-18 | 23,500 | — | $0 | 23,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-08 | 2024-04-10 | 26,270 | — | $0 | 206,256 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-08 | 2024-04-10 | 26,270 | $9.45 | $248.3K | 212,005 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 1,441 | $242.95 | $350.1K | 210,564 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 3,730 | $244.12 | $910.6K | 206,834 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 5,663 | $244.86 | $1.39M | 201,171 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 2,078 | $245.71 | $510.6K | 199,093 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 5,028 | $246.96 | $1.24M | 194,065 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 3,464 | $247.76 | $858.2K | 190,601 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-08 | 2024-04-10 | 4,866 | $248.59 | $1.21M | 185,735 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-05 | 2024-04-05 | 27,613 | — | $0 | 232,526 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-05 | 2024-04-05 | 27,613 | $9.45 | $260.9K | 213,348 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 612 | $241.15 | $147.6K | 211,316 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 6,679 | $242.42 | $1.62M | 204,637 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 9,264 | $243.20 | $2.25M | 195,373 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 3,966 | $244.22 | $968.6K | 191,407 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 5,228 | $245.35 | $1.28M | 186,179 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 444 | $245.92 | $109.2K | 185,735 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-05 | 2024-04-05 | 1,420 | $240.10 | $340.9K | 211,928 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-04 | 2024-04-05 | 18,710 | — | $0 | 260,139 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 2,549 | $245.14 | $624.9K | 188,230 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 1,558 | $246.13 | $383.5K | 186,672 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 737 | $247.14 | $182.1K | 185,935 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 200 | $248.43 | $49.7K | 185,735 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-04 | 2024-04-05 | 18,710 | $9.45 | $176.8K | 204,445 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 6,273 | $241.07 | $1.51M | 198,172 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 5,299 | $242.25 | $1.28M | 192,873 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 1,467 | $243.00 | $356.5K | 191,406 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-04 | 2024-04-05 | 627 | $244.31 | $153.2K | 190,779 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise deriv | 2024-04-03 | 2024-04-05 | 27,407 | — | $0 | 278,849 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | M Exercise | 2024-04-03 | 2024-04-05 | 27,407 | $9.45 | $259.0K | 213,142 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 185 | $242.00 | $44.8K | 212,957 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 2,294 | $243.64 | $558.9K | 210,663 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 4,301 | $244.58 | $1.05M | 206,362 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 18,806 | $245.34 | $4.61M | 187,556 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2024-04-03 | 2024-04-05 | 1,821 | $246.31 | $448.5K | 185,735 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2023-06-16 | 2023-06-21 | 23,500 | — | $0 | 23,500 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | F Tax w/h | 2023-01-16 | 2024-01-18 | 2,254 | $243.92 | $549.8K | 20,001 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2023-01-16 | 2023-01-18 | 26,668 | — | $0 | 26,668 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2022-06-17 | 2022-06-22 | 34,300 | — | $0 | 34,300 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer | 2021-07-21 | 2021-07-23 | 12,840 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | A Award deriv | 2021-06-18 | 2021-06-22 | 23,344 | — | $0 | 23,344 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-05-20 | 2021-05-24 | 1,962 | — | $0 | 12,307 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-05-20 | 2021-05-24 | 533 | — | $0 | 12,840 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2021-02-22 | 2021-02-23 | 50,000 | — | $0 | 50,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 295,794 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-30 | 152,576 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-30 | 295,794 | — | $0 | 347,522 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-30 | 152,576 | — | $0 | 500,098 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2020-05-26 | 2020-05-28 | 10,514 | — | $0 | 10,514 | SEC↗ |
| INCY INCYTE CORP | A Award | 2020-05-26 | 2020-05-28 | 1,282 | — | $0 | 256,813 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-05-14 | 2020-05-18 | 3,468 | — | $0 | 10,345 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2020-03-27 | 2020-09-30 | 76,288 | — | $0 | 152,576 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2020-03-05 | 2020-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2019-08-06 | 2019-08-06 | 77,934 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2019-08-06 | 2019-08-06 | 77,934 | $18.32 | $1.43M | 333,465 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2019-08-06 | 2019-08-06 | 77,934 | $82.20 | $6.41M | 255,531 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2019-08-02 | 2019-08-06 | 22,066 | — | $0 | 77,934 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2019-08-02 | 2019-08-06 | 22,066 | $18.32 | $404.2K | 277,597 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2019-08-02 | 2019-08-06 | 22,066 | $84.41 | $1.86M | 255,531 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-05-15 | 2019-05-17 | 2,726 | — | $0 | 6,877 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2019-04-26 | 2019-04-29 | 12,472 | — | $0 | 12,472 | SEC↗ |
| INCY INCYTE CORP | A Award | 2019-04-26 | 2019-04-29 | 1,520 | — | $0 | 255,531 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2019-03-07 | 2019-03-11 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2018-11-20 | 2018-11-23 | 4,000 | $117.88 | $471.5K | 161,128 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | P Buy | 2018-11-19 | 2018-11-19 | 4,000 | $124.00 | $496.0K | 157,128 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | S Sale | 2018-06-11 | 2018-06-12 | 73,526 | $287.46 | $21.14M | 655,540 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-05-09 | 2018-05-11 | 2,174 | — | $0 | 4,151 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2018-05-01 | 2018-05-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2018-03-01 | 2018-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-11-29 | 2017-11-30 | 1,977 | — | $0 | 1,977 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-11-16 | 2017-11-20 | 28,507 | $105.24 | $3.00M | 269,011 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2017-05-26 | 2017-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award | 2017-04-03 | 2017-04-05 | 10,273 | $0.73 | $7.5K | 18,819 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-03-17 | 2017-03-20 | 41,693 | — | $0 | 100,000 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-03-17 | 2017-03-20 | 41,693 | $148.18 | $6.18M | 297,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-03-17 | 2017-03-20 | 41,693 | $18.32 | $763.8K | 339,211 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-03-16 | 2017-03-20 | 5,458 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-03-16 | 2017-03-20 | 2,849 | — | $0 | 141,693 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-03-16 | 2017-03-20 | 2,849 | $18.32 | $52.2K | 305,825 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-03-16 | 2017-03-20 | 5,458 | $18.32 | $100.0K | 302,976 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-03-16 | 2017-03-20 | 8,307 | $151.45 | $1.26M | 297,518 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2017-03-02 | 2017-03-06 | 49,600 | — | $0 | 49,600 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2017-02-23 | 2017-02-27 | 50,000 | — | $0 | 144,542 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2017-02-23 | 2017-02-27 | 50,000 | $18.32 | $916.0K | 347,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2017-02-23 | 2017-02-27 | 50,000 | $120.32 | $6.02M | 297,518 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award | 2017-01-03 | 2017-01-05 | 4,870 | $0.77 | $3.7K | 8,546 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award | 2016-10-03 | 2016-10-20 | 3,676 | $1.02 | $3.7K | 3,676 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award deriv | 2016-07-22 | 2016-07-26 | 287,115 | — | $0 | 287,115 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award deriv | 2016-07-22 | 2016-08-23 | 306,256 | — | $0 | 306,256 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award | 2016-07-22 | 2016-07-26 | 729,066 | — | $0 | 729,066 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award | 2016-07-22 | 2016-07-26 | 143,557 | — | $0 | 143,703 | SEC↗ |
| MDGL SYNTA PHARMACEUTICALS CORP | A Award | 2016-07-22 | 2016-07-26 | 146 | — | $0 | 146 | SEC↗ |
| MDGL MADRIGAL PHARMACEUTICALS, | A Award | 2016-07-22 | 2016-08-23 | 153,128 | — | $0 | 153,274 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2016-06-14 | 2016-06-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2016-05-27 | 2016-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-11-18 | 2015-11-19 | 125,000 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-11-18 | 2015-11-19 | 38,868 | $115.12 | $4.47M | 297,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-11-18 | 2015-11-19 | 86,132 | $115.42 | $9.94M | 336,386 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-11-18 | 2015-11-19 | 125,000 | $17.79 | $2.22M | 422,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-11-17 | 2015-11-19 | 94,379 | — | $0 | 125,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-11-17 | 2015-11-19 | 5,621 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-11-17 | 2015-11-19 | 42,948 | $112.53 | $4.83M | 347,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-11-17 | 2015-11-19 | 7,052 | $112.71 | $794.8K | 390,466 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-11-17 | 2015-11-19 | 100,000 | $17.79 | $1.78M | 397,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-11-17 | 2015-11-19 | 50,000 | $111.37 | $5.57M | 297,518 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2015-07-01 | 2015-07-06 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 1,136 | — | $0 | 6,817 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award | 2015-07-01 | 2015-07-06 | 5,681 | — | $0 | 5,681 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-06-26 | 2015-06-30 | 8,214 | — | $0 | 8,214 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2015-06-26 | 2015-06-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2015-06-12 | 2015-06-16 | 19,495 | — | $0 | 19,495 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-27 | 2015-05-28 | 69,132 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-27 | 2015-05-28 | 52,696 | $107.66 | $5.67M | 313,954 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-27 | 2015-05-28 | 16,436 | $107.19 | $1.76M | 297,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-27 | 2015-05-28 | 69,132 | $14.72 | $1.02M | 366,650 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-26 | 2015-05-28 | 127,619 | — | $0 | 69,132 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 2,619 | $107.83 | $282.4K | 422,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 50,000 | $107.00 | $5.35M | 372,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-26 | 2015-05-28 | 127,619 | $14.72 | $1.88M | 425,137 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 22,642 | $107.15 | $2.43M | 297,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 50,000 | $107.00 | $5.35M | 320,160 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-26 | 2015-05-28 | 2,358 | $107.36 | $253.2K | 370,160 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-22 | 2015-05-26 | 79,592 | — | $0 | 196,751 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2015-05-22 | 2015-05-27 | 15,000 | — | $0 | 15,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-22 | 2015-05-26 | 79,592 | $14.72 | $1.17M | 377,110 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-22 | 2015-05-26 | 25,000 | $107.75 | $2.69M | 322,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-22 | 2015-05-26 | 15,200 | $108.50 | $1.65M | 347,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-22 | 2015-05-26 | 14,392 | $108.34 | $1.56M | 362,718 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-22 | 2015-05-26 | 25,000 | $107.88 | $2.70M | 297,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-21 | 2015-05-26 | 13,846 | — | $0 | 276,343 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2015-05-21 | 2015-05-26 | 8,805 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-21 | 2015-05-26 | 8,263 | $108.75 | $898.6K | 311,906 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-21 | 2015-05-26 | 13,846 | $14.72 | $203.8K | 320,169 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2015-05-21 | 2015-05-26 | 8,805 | $14.72 | $129.6K | 306,323 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-05-21 | 2015-05-26 | 14,388 | $108.92 | $1.57M | 297,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-02-13 | 2015-02-18 | 60,000 | $74.39 | $4.46M | 297,518 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2015-02-13 | 2015-02-18 | 60,000 | $74.25 | $4.46M | 357,518 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 5,000 | $36.53 | $182.7K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 5,000 | $36.53 | $182.7K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other deriv | 2015-01-29 | 2015-01-30 | 15,000 | $36.53 | $548.0K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 5,000 | $36.53 | $182.7K | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2015-01-29 | 2015-01-30 | 5,361 | — | $0 | 5,000 | SEC↗ |
| VSTM Verastem, Inc. | P Buy | 2014-12-24 | 2014-12-29 | 3,000 | $8.31 | $24.9K | 3,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-12-05 | 2014-12-08 | 9,689 | $33.85 | $328.0K | 10,361 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-12-04 | 2014-12-08 | 5,000 | — | $0 | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise deriv | 2014-12-04 | 2014-12-08 | 15,000 | — | $0 | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | S Sale | 2014-12-04 | 2014-12-08 | 20,000 | $33.67 | $673.4K | 20,050 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-12-04 | 2014-12-08 | 5,000 | $14.37 | $71.8K | 40,050 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | M Exercise | 2014-12-04 | 2014-12-08 | 15,000 | $19.78 | $296.7K | 35,050 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 11,145 | — | $0 | 0 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | D To issuer deriv | 2014-11-17 | 2014-11-19 | 8,575 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-06 | 2014-11-07 | 29,166 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-11-06 | 2014-11-07 | 156,487 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-11-06 | 2014-11-07 | 185,653 | $67.87 | $12.60M | 417,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-06 | 2014-11-07 | 156,487 | $9.41 | $1.47M | 574,005 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-11-06 | 2014-11-07 | 29,166 | $13.34 | $389.1K | 603,171 | SEC↗ |
| CERU Cerulean Pharma Inc. | A Award deriv | 2014-10-29 | 2014-10-31 | 100,000 | — | $0 | 113,786 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2014-07-01 | 2014-07-03 | 10,000 | — | $0 | 10,000 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-05-28 | 2014-05-28 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award deriv | 2014-05-21 | 2014-05-22 | 5,000 | — | $0 | 5,000 | SEC↗ |
| DRTX Durata Therapeutics, Inc. | A Award deriv | 2014-05-21 | 2014-05-23 | 8,575 | — | $0 | 19,720 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2014-05-21 | 2014-05-22 | 5,000 | — | $0 | 20,054 | SEC↗ |
| VSTM Verastem, Inc. | A Award deriv | 2014-05-12 | 2014-05-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| SNTA SYNTA PHARMACEUTICALS CORP | A Award deriv | 2014-03-03 | 2014-03-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-20 | 2014-02-21 | 33,354 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-20 | 2014-02-21 | 33,354 | $3.11 | $103.7K | 450,872 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-20 | 2014-02-21 | 33,354 | $63.51 | $2.12M | 417,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-19 | 2014-02-19 | 40,919 | — | $0 | 33,354 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-19 | 2014-02-19 | 40,919 | $62.66 | $2.56M | 417,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-19 | 2014-02-19 | 40,919 | $3.11 | $127.3K | 458,437 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-18 | 2014-02-19 | 193,520 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-18 | 2014-02-19 | 185,753 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-18 | 2014-02-19 | 120,171 | — | $0 | 74,273 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-18 | 2014-02-19 | 181,426 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-18 | 2014-02-19 | 39,166 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-18 | 2014-02-19 | 181,426 | $11.98 | $2.17M | 598,944 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-18 | 2014-02-19 | 39,166 | $8.99 | $352.1K | 638,110 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-18 | 2014-02-19 | 720,036 | $65.82 | $47.39M | 417,518 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-18 | 2014-02-19 | 120,171 | $3.11 | $373.7K | 1,137,554 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-18 | 2014-02-19 | 185,753 | $5.46 | $1.01M | 1,017,383 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-18 | 2014-02-19 | 193,520 | $8.99 | $1.74M | 831,630 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2014-02-14 | 2014-02-19 | 10,227 | — | $0 | 181,426 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2014-02-14 | 2014-02-19 | 10,227 | $11.98 | $122.5K | 427,745 | SEC↗ |
| INCY INCYTE CORP | S Sale | 2014-02-14 | 2014-02-19 | 10,227 | $65.52 | $670.1K | 417,518 | SEC↗ |
| INCY INCYTE CORP | A Award deriv | 2014-01-21 | 2014-01-23 | 7,500 | — | $0 | 7,500 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2014-01-10 | 2014-01-14 | 1,227 | — | $0 | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2014-01-10 | 2014-01-14 | 2,454 | — | $0 | 15,054 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | J Other | 2014-01-10 | 2014-01-14 | 1,227 | — | $0 | 0 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-12-31 | 2014-01-02 | 361 | $20.73 | $7.5K | 12,600 | SEC↗ |
| INCY INCYTE CORP | F Tax w/h | 2013-12-20 | 2013-12-20 | 24,350 | $50.11 | $1.22M | 417,518 | SEC↗ |
| AUXL AUXILIUM PHARMACEUTICALS I | A Award | 2013-09-30 | 2013-10-01 | 411 | $18.20 | $7.5K | 12,239 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-09-10 | 2013-09-12 | 43,125 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-09-10 | 2013-09-12 | 189,105 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise deriv | 2013-09-10 | 2013-09-12 | 144,559 | — | $0 | 0 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-09-10 | 2013-09-12 | 144,559 | $8.64 | $1.25M | 536,427 | SEC↗ |
| INCY INCYTE CORP | M Exercise | 2013-09-10 | 2013-09-12 | 43,125 | $8.64 | $372.6K | 579,552 | SEC↗ |